Company Filing History:
1 out of 832,843 Years Active: 2011
Title: Kenneth Drasner: Innovator in Guanidine Compounds
Introduction
Kenneth Drasner is a notable inventor based in Kentfield, California. He has made significant contributions to the field of anesthetics and treatments for nervous system disorders. His innovative work focuses on the development of novel guanidine compounds that serve as effective sodium channel blockers.
Latest Patents
Drasner holds a patent for "Guanidine compounds as anesthetics and for treatment of nervous system disorders." This patent describes novel guanidine compounds that are effective in alleviating neuropathic pain and providing neuroprotective effects. The compounds are particularly useful as local spinal and/or epidural anesthetics, as well as for producing anti-convulsant effects.
Career Highlights
Throughout his career, Kenneth Drasner has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to improve the quality of life for individuals suffering from various neurological conditions.
Collaborations
Drasner has collaborated with Kevin T Weber, further enhancing the impact of his research in the field of anesthetics and nervous system treatments.
Conclusion
Kenneth Drasner's contributions to the development of guanidine compounds highlight his role as an important inventor in the medical field. His innovative work continues to pave the way for advancements in anesthetic treatments and neurological care.